Research protocol FAQ

Q1.Do I need to use every day?

Most peptides work best with consistent daily dosing. GH secretagogues are typically dosed 1–2x daily. BPC-157 daily for 6–12 weeks. Missing occasional doses won't ruin a cycle, but consistency is what drives results.

Q2.What time of day should I inject?

Timing depends on the peptide. GH secretagogues work best in a fasted state — typically morning (fasted) and/or pre-bed (at least 2 hours after eating). BPC-157 has no strong timing requirement. Ipamorelin is often dosed pre-bed to amplify the natural overnight GH pulse. Check the specific research overview for your compound.

Q3.Do I need to be fasted for GH peptides?

Yes — food, especially carbohydrates, spikes insulin which blunts GH release. For GH secretagogues (CJC, ipamorelin, GHRP), inject at least 2 hours after your last meal and avoid eating for 30–60 minutes after injection.

Q4.What if I miss a dose?

Take the next scheduled dose as normal. Don't double-dose to compensate. One missed dose doesn't meaningfully impact a cycle.

Q5.Will peptides show on a drug test?

Depends on the test. Standard employment drug screens don't test for peptides. WADA sports drug tests do test for many peptides (check the WADA prohibited list for your specific compound). Peptides clear from urine relatively quickly compared to steroids.

Q6.Can I drink alcohol on a peptide cycle?

Occasional alcohol is not contraindicated with most research peptides. Heavy or regular alcohol consumption blunts GH release significantly and undermines GH secretagogue cycles. Alcohol also disrupts sleep quality — which is when GH pulses primarily occur.

Q7.Can I train hard during a cycle?

Yes — for most peptides, training enhances the response. GH secretagogues work synergistically with resistance training. BPC-157 protocols are often specifically designed around training. The exception is active injury — don't train through an acute injury even if on a healing protocol.

Q8.How do I know if it's working?

Track quantitative metrics from day 1: body weight, waist measurement, performance metrics (weights lifted, run times), sleep quality rating, pain scores (for healing protocols). Subjective feeling is unreliable over weeks. Bloodwork at 6–8 weeks (especially IGF-1 for GH-axis protocols) gives objective confirmation.

Q9.Why do I feel nothing in week 1?

Most peptides take 2–4 weeks before effects are noticeably measurable. The exception is acute effects like appetite suppression with GLP-1 agonists (often felt within 24–48 hours) or cognitive clarity with Semax (sometimes acute). Don't judge a cycle by week 1.

Q10.Can I use two peptides at once?

Don't stack on your first cycle. Run one compound, establish how your body responds, then consider stacking. Common synergistic combinations (CJC + ipamorelin, BPC + TB-500) are well-documented but best approached once you know your individual response to each.

Q11.Do I need post-cycle therapy (PCT)?

No PCT is required for most research peptides. Unlike anabolic steroids, most peptides don't suppress the HPTA, so there's nothing to 'recover' in the anabolic steroid sense. GH secretagogues can cause mild pituitary downregulation with long continuous use — which is addressed by cycling off, not by pharmaceutical PCT.

Q12.Should I take a break between cycles?

Yes — cycling off is standard practice. Typical recommendation is equal off time to on time (e.g., 12 weeks on, 8–12 weeks off). This prevents receptor desensitisation, maintains responsiveness, and allows natural hormone rhythms to normalise.

Q13.Will I keep results after stopping?

Healing effects (BPC-157, TB-500): structural repair persists. Body composition effects from GH-axis peptides: largely maintained if you keep training and eating well. Fat loss from GLP-1 agonists: weight often returns after stopping unless lifestyle changes are maintained. Cognitive effects: require ongoing dosing.

Q14.What local tissue reactions are observed at the injection site in subcutaneous research models?

Mild erythema immediately post-injection is a common observation that typically resolves within an hour. Persistent erythema, spreading induration, oedema, or warmth beyond 24 hours are atypical findings that suggest contamination or non-sterile technique. Discontinue use of the implicated vial and document the observation.

Q15.What causes subcutaneous nodule formation in injection-site research?

Small transient nodules are typically attributable to fluid pooling in the subcutaneous layer and resolve within minutes to hours. Persistent firm nodules indicate lipohypertrophy, a well-documented consequence of repetitive injection at the same anatomical site. Site rotation is standard protocol to avoid this confound.

Q16.Should subcutaneous injection protocols be paused during acute illness in animal models?

Research context varies. Active bacterial infection is generally a reason to pause immune-modulating peptide protocols. For most peptides and minor systemic illness, continuation is documented in the literature, though stressed immune conditions may affect observed outcomes. Always avoid injection through compromised tissue.

Q17.How do I store my reconstituted vial?

Refrigerate at 2–8°C immediately after reconstitution. Use within 28 days (with BAC water). Keep away from direct light. Do not freeze unless you need to extend beyond 28 days — in which case freeze in a single session, not with repeated freeze-thaw cycles.

Q18.Is the peptide still good if I left it out overnight?

Depends on conditions. Room temperature for one night (under 20°C) is unlikely to have caused significant degradation. Over 24 hours at room temperature, or any time above 30°C, increases degradation risk meaningfully. When in doubt, check that the solution remains clear and colourless. If it looks fine, it's probably fine — but potency may be modestly reduced.

Q19.Why does my dose calculation give me a fraction of a unit?

Peptide doses at mcg scale are not always evenly divisible by the concentration in a syringe. Round to the nearest whole unit or the nearest unit your syringe can measure. At these volumes, a 1-unit rounding difference is typically under 5% of the dose and clinically irrelevant.

Q20.What should I do if I think I injected too much?

Most research peptides have wide margins between therapeutic and toxic doses. If you over-calculated significantly, monitor for expected side effects (nausea, headache, water retention, hunger). If symptoms are severe or involve chest pain, breathing difficulty, or a strong allergic reaction, seek medical attention. Most mild overdose symptoms resolve within hours.